申请人:——
公开号:US20010039277A1
公开(公告)日:2001-11-08
NPY antagonists, methods of using such NPY antagonists and pharmaceutical compositions containing such NPY antagonists. The NPY antagonists are useful for the treatment of NPY mediated disease/conditions including obesity.
NPY拮抗剂,使用此类NPY拮抗剂的方法以及含有此类NPY拮抗剂的药物组合物。这些NPY拮抗剂对于治疗由NPY介导的疾病/症状,包括肥胖症,是有用的。